FibroBiologics, Inc. Common Stock
Stock Chart, Company Information, and Scan Results
$0.34(as of Nov 13, 3:59 PM EST)
Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.
FibroBiologics, Inc. Common Stock Company Information, Fundamentals, and Technical Indicators
Stock Price$0.34
Ticker SymbolFBLG
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees13
CountyUSA
Market Cap$16.9M
EBIDTA-17.5M
P/E Ratio-0.78
Forward P/E Ratio0.00
Earnings per Share-0.48
Profit Margin-Infinity%
RSI36.73
Shares Outstanding51.5M
ATR0.04
52-Week High2.98
Volume843,902
52-Week Low0.32
Book Value0.1M
P/B Ratio115.68
Upper Keltner0.47
P/S Ratio26.10
Lower Keltner0.30
Next Earnings Date11/18/2025
Cash Surplus-1.9M
Next Ex-Dividend DateUnknown
FibroBiologics, Inc. operates as a cell therapy, regenerative medicine company. It is developing a pipeline of treatments and potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials. The company was founded in 2021 and is based in Houston, Texas.
FibroBiologics, Inc. Common Stock In Our Stock Scanner
As of Nov 14, 2025
Scan Name: Falling WedgeScan Type: Chart Pattern Scans
As of ---
Join Our Free Email List
Get emails from us about ways to potentially make money in the stock market.